溃疡性结肠炎
益生菌
免疫系统
背景(考古学)
医学
菌群(微生物学)
粘膜免疫
炎症性肠病
重症监护医学
干预(咨询)
动作(物理)
梅德林
肠易激综合征
肠道菌群
临床试验
透视图(图形)
炎症反应
人体研究
生物信息学
炎症性肠病
炎症
结肠炎
免疫学
肠粘膜
粘膜炎症
促炎细胞因子
失调
肠道疾病
作者
Tianxiang Xue,Yanli Zhu,Mengwei Chang,Yufeng He,Guangsu Zhu
标识
DOI:10.1021/acs.jafc.5c08885
摘要
Ulcerative Colitis (UC) is an inflammatory disorder of the intestinal mucosa, characterized by recurrent inflammatory responses and dysfunction of the intestinal barrier. Recent research has revealed the crucial role of postbiotics in modulating gut flora and immune responses. However, the specific mechanisms by which postbiotics and their active ingredients influence gastrointestinal diseases remain unclear. Here, we review the literature on the sources and preparation of postbiotics. We also discuss the latest progress in understanding the pathways by which the active ingredients of postbiotics regulate UC. By understanding the effects of postbiotic bioactive components on the intestinal barrier, microbiota regulation, and immune metabolism, we can examine the potential to manipulate intestinal inflammation through postbiotics and delay the progression of UC. Although clinical validation of postbiotic applications is currently limited, these findings present an appealing new perspective for advancing probiotic research in the context of UC.
科研通智能强力驱动
Strongly Powered by AbleSci AI